Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Capper

Showing results (71-80 of 350) with videos related to

Pageof 35
Sort By:
Frontiers in Oncology|September 19, 2022
[<sup>68</sup>Ga]Ga-PSMA PET/MRI, histological PSMA expression and preliminary experience with [<sup>177</sup>Lu]Lu-PSMA therapy in relapsing high-grade gliomaPeter Truckenmueller, Josefine Graef, Michael Scheel, et al.
Acta Neuropathologica|June 4, 2011
Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibodyDavid Capper, Matthias Preusser, Antje Habel, et al.
Lancet (London, England)|September 22, 2023
Primary brain tumours in adultsMartin J van den Bent, Marjolein Geurts, Pim J French, et al.
Neuro-Oncology|September 1, 2018
Satisfying your neuro-oncologist: a fast approach to routine molecular glioma diagnosticsJürgen Hench, Michel Bihl, Ivana Bratic Hench, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 25, 2013
No evidence for BRAF-V600E mutations in gastroeosophageal tumors: results from a high-throughput analysis of 534 cases using a mutation-specific antibodyMatthias Preusser, Anna S Berghoff, David Capper, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 24, 2012
Expression of BRAF V600E mutant protein in epithelial ovarian tumorsMatthias Preusser, David Capper, Anna S Berghoff, et al.
Journal of Neuro-Oncology|April 27, 2021
High-grade astrocytoma with piloid features (HGAP): the Charité experience with a new central nervous system tumor entityKatja Bender, Eilís Perez, Mihaela Chirica, et al.
Frontiers in Oncology|January 22, 2025
Real-world experience with TTFields in glioma patients with emphasis on therapy usageClaudius Jelgersma, Joan Alsolivany, Gülsüm Akkas, et al.
Archives of Pathology & Laboratory Medicine|May 9, 2013
Detection of BRAF p.V600E Mutations in Melanoma by Immunohistochemistry Has a Good Interobserver ReproducibilityCristi Marin, Alain Beauchet, David Capper, et al.
Acta Neuropathologica|May 4, 2015
Pediatric atypical choroid plexus papilloma reconsidered: increased mitotic activity is prognostic only in older childrenChristian Thomas, Vincent Ruland, Uwe Kordes, et al.
Pageof 35

Showing results (71-80 of 350) with videos related to

Sort By:
Pageof 35
Frontiers in Oncology|September 19, 2022
[<sup>68</sup>Ga]Ga-PSMA PET/MRI, histological PSMA expression and preliminary experience with [<sup>177</sup>Lu]Lu-PSMA therapy in relapsing high-grade gliomaPeter Truckenmueller, Josefine Graef, Michael Scheel, et al.
Acta Neuropathologica|June 4, 2011
Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibodyDavid Capper, Matthias Preusser, Antje Habel, et al.
Lancet (London, England)|September 22, 2023
Primary brain tumours in adultsMartin J van den Bent, Marjolein Geurts, Pim J French, et al.
Neuro-Oncology|September 1, 2018
Satisfying your neuro-oncologist: a fast approach to routine molecular glioma diagnosticsJürgen Hench, Michel Bihl, Ivana Bratic Hench, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|January 25, 2013
No evidence for BRAF-V600E mutations in gastroeosophageal tumors: results from a high-throughput analysis of 534 cases using a mutation-specific antibodyMatthias Preusser, Anna S Berghoff, David Capper, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 24, 2012
Expression of BRAF V600E mutant protein in epithelial ovarian tumorsMatthias Preusser, David Capper, Anna S Berghoff, et al.
Journal of Neuro-Oncology|April 27, 2021
High-grade astrocytoma with piloid features (HGAP): the Charité experience with a new central nervous system tumor entityKatja Bender, Eilís Perez, Mihaela Chirica, et al.
Frontiers in Oncology|January 22, 2025
Real-world experience with TTFields in glioma patients with emphasis on therapy usageClaudius Jelgersma, Joan Alsolivany, Gülsüm Akkas, et al.
Archives of Pathology & Laboratory Medicine|May 9, 2013
Detection of BRAF p.V600E Mutations in Melanoma by Immunohistochemistry Has a Good Interobserver ReproducibilityCristi Marin, Alain Beauchet, David Capper, et al.
Acta Neuropathologica|May 4, 2015
Pediatric atypical choroid plexus papilloma reconsidered: increased mitotic activity is prognostic only in older childrenChristian Thomas, Vincent Ruland, Uwe Kordes, et al.
Pageof 35